Julien Vibert (李满山)
julienmanshan.bsky.social
Julien Vibert (李满山)
@julienmanshan.bsky.social
MD, PhD | Medical Oncologist & Postdoctoral Researcher | AI & Computational Oncology | Sarcoma & Rare Cancers | Gustave Roussy & Heidelberg | Kung Fu practitioner | Philosophy lover |
Reposted by Julien Vibert (李满山)
Using genomic data, researchers have uncovered the origins and cultural practices of the people of Shimao, a 4,000-year-old fortified settlement in northern China

go.nature.com/4olfAV9
Ancient DNA offers clues about mysterious prehistoric settlement in China
Using genomic data, researchers have uncovered the origins and cultural practices of the people of Shimao, a 4,000-year-old fortified settlement in northern China.
go.nature.com
November 28, 2025 at 1:02 PM
Reposted by Julien Vibert (李满山)
Join us:

With @abigailsuwala.bsky.social we are looking for a postdoc to drive our spatial transcriptomics analysis efforts of brain tumours.

If you enjoy multidisciplinary biomedical research, big data and coding, you are in the right place.

karriere.klinikum.uni-heidelberg.de/index.php?ac...
November 28, 2025 at 2:11 PM
Reposted by Julien Vibert (李满山)
Multi-omics profiling identified two epithelioid sarcoma molecular subtypes with distinct signaling and immune characteristics

onlinelibrary.wiley.com/doi/10.1002/...
November 28, 2025 at 5:30 PM
Reposted by Julien Vibert (李满山)
Reposted by Julien Vibert (李满山)
This will be a very exciting meeting!
Looking forward to see you there
Please spread the word
We have a fantastic line up of speakers for our 2026 Journal Meeting organised by @amatrudalab.bsky.social, @bandolab.bsky.social, @banitolab.bsky.social and Elaine Mardis @nationwidekids.bsky.social!

🚨Register your interest now so you're first to get updates🚨

www.biologists.com/meetings/dmm...
November 26, 2025 at 5:46 AM
Reposted by Julien Vibert (李满山)
In a phase 1 trial, treatment of fibrolamellar hepatocellular carcinoma with a therapeutic peptide vaccine targeting the DNAJB1::PRKACA fusion, together with nivolumab and ipilimumab, was safe and led to encouraging preliminary clinical responses. https://www.nature.com/articles/s41591-025-03995-y
November 26, 2025 at 1:01 PM
Reposted by Julien Vibert (李满山)
Blending ‘old-fashioned’ logic systems with the neural networks that power large language models is one of the hottest trends in AI

go.nature.com/4oUA1cw
This AI combo could unlock human-level intelligence
Blending ‘old-fashioned’ logic systems with the neural networks that power large language models is one of the hottest trends in artificial intelligence.
go.nature.com
November 25, 2025 at 2:35 PM
Reposted by Julien Vibert (李满山)
🚀 Ready to lead the next frontier of AI in health care and research?

UHN is hiring a Coordinator to spearhead the Blue Vest #AI Initiative at @PMResearch_UHN @PM_CDI to train student volunteers and empower clinicians & scientists.

📍 Toronto
🔗 Apply: smrtr.io/vC7zh
smrtr.io
November 24, 2025 at 7:25 PM
Reposted by Julien Vibert (李满山)
Although sensing is one of the more established quantum technologies, translating quantum science into real-world biomedical impact requires further effort to overcome technical hurdles as well as structural and societal challenges, according to a Comment article in Nature Reviews Physics. 🔒
How quantum biosensing is transforming healthcare - Nature Reviews Physics
Although sensing is one of the more established quantum technologies, translating quantum science into real-world biomedical impact requires further effort to overcome technical hurdles as well as structural and societal challenges.
go.nature.com
November 22, 2025 at 2:11 PM
Reposted by Julien Vibert (李满山)
We are honored that our lab was awarded with the Henrik Kreibohm Research Award to seed-fund our immunotherapy efforts in DSRCT

www.deutsches-stiftungszentrum.de/stiftungen/h...

onlinelibrary.wiley.com/doi/10.1002/...

Many thanks to the foundation and Kreibohm family for their generous support!
November 21, 2025 at 8:20 AM
Reposted by Julien Vibert (李满山)
Nature research paper: Genetic elements promote retention of extrachromosomal DNA in cancer cells

go.nature.com/3JLvsSJ
Genetic elements promote retention of extrachromosomal DNA in cancer cells - Nature
A combination of genome-wide functional screening, imaging and chromatin profiling identifies a new class of highly prevalent genomic elements that help retain extrachromosomal DNA copies in dividing cells and persist across generations.
go.nature.com
November 20, 2025 at 9:13 AM
Reposted by Julien Vibert (李满山)
I am honoured to step into the role of @uhn.ca
Executive AI Scientific Director and Co-Director of the
@uhnaihub.bsky.social

This is a major opportunity to accelerate how we bring responsible, transparent and effective AI into patient care, research, education and operations across UHN.
November 11, 2025 at 11:14 PM
Reposted by Julien Vibert (李满山)
Rare cancers make up 22% of adult cases but cause 30% of cancer deaths.

At EORTC, we fight for patients with rare & ultra-rare cancers, creating trials that set new standards of care.
Help us keep hope alive.

🔗 Donate: donate.eortcresearchfund.org/eoy/

#NoPatientLeftBehind
November 18, 2025 at 10:53 AM
Reposted by Julien Vibert (李满山)
📢 @fionakolbinger.bsky.social and @jnkt.bsky.social characterize the discordance between metrics used to evaluate AI tools and their clinical impact, proposing a framework to reduce this disconnect. www.nature.com/articles/s43... @tudresden.bsky.social @ekfzdigital.bsky.social

🔓 rdcu.be/eQmQp
Adaptive validation strategies for real-world clinical artificial intelligence - Nature Computational Science
Technical metrics used to evaluate medical artificial intelligence tools often fail to predict their clinical impact. We characterize this discordance and propose a framework of study designs to guide...
www.nature.com
November 17, 2025 at 3:23 PM
Reposted by Julien Vibert (李满山)
Register for the next EuSARC conference in Oslo, Norway, in June 2026

oslocancercluster.no/events/8th-e...
November 15, 2025 at 8:26 PM
Reposted by Julien Vibert (李满山)
Brian lived a life driven by compassion, service, & deep impact on the global #sarcomacommunity. We will honor him by staying steadfast in our commitment to research, collaboration, and supporting every patient and family affected by this disease.
November 15, 2025 at 8:17 PM
Reposted by Julien Vibert (李满山)
🚀 Excited to share our preprint scConcept: a contrastive pretraining framework for technology-agnostic single-cell representations.
We move beyond reconstruction to learn rich, cell-level embeddings for diverse omics.
📘 www.biorxiv.org/content/10.1...
scConcept: Contrastive pretraining for technology-agnostic single-cell representations beyond reconstruction
Recent large-scale single-cell foundation models have shown promise for exploring cellular states, yet they often underperform compared to simpler, domain-specific methods, raising concerns about…
www.biorxiv.org
November 13, 2025 at 5:17 PM
Reposted by Julien Vibert (李满山)
Reposted by Julien Vibert (李满山)
For a quick summary, read the Research Briefing on this work, here:

www.nature.com/articles/s41...
November 11, 2025 at 5:49 PM
Reposted by Julien Vibert (李满山)
#PEAKtrial in #GIST positive as it could be.. great news for parients!! Congrats to @cogent
mPFS of 16.5 months is very impressive. Topline suggests new standard of care!!

@saxotomy.bsky.social @herbloongmd.bsky.social and @ all other folks out there
November 10, 2025 at 2:19 PM
Reposted by Julien Vibert (李满山)
I'm impressed by how far this model class has taken us—MOFA-FLEX may be the final iteration—a framework geared more towards generating models than being a standalone model itself. User-friendly, probabilistic programming rocks! We look forward to your feedback and experiences trying it out!
Are you using any of our factor models, such as MOFA? 🛵
You might’ve found it challenging to tailor them to your specific use cases - not anymore!

Introducing MOFA-FLEX: a flexible, modular factor analysis framework designed for customizable modeling across diverse multi-omics data scenarios. 1/n
November 8, 2025 at 9:06 PM
Reposted by Julien Vibert (李满山)
🎗️ Attending #CTOS2025? Don’t miss the Foundational Science of Sarcomas Symposium!

This year’s highlights include sessions on
🔹 Cancer Metabolism & Drug Development
🔹 AI Applications in Sarcoma Diagnostics & Care
🔹 Publishing Your Research — In Conversation with Editors of Leading Oncology Journals
November 7, 2025 at 3:20 PM
Reposted by Julien Vibert (李满山)
🚀 Prophet v3 is out!
AI that predicts how cells respond to genetic & chemical perturbations across readouts.
Now scales to 1.9 M molecules + in vitro validation of melanoma-specific hits 🧬💊
📄 biorxiv.org/content/10.1...
#AI #Biology #DeepLearning
November 4, 2025 at 5:40 PM